{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "patents/US20230407336A1.pdf"}, "page_content": "11. The system according to claim 9, wherein the wave- like structure is configured to suppress the multiple cell encapsulation ratio less than 6%.\n\n12. The system according to claim 1, wherein the droplet comprises isolated mitochondria and a single cell has a diameter of at less than 40 wm.\n\n13. The system according to claim 1, wherein an effi- ciency of mitochondrial transfer is at least 75%.\n\n14. The system according to claim 1, wherein the system is configured to yield at least 2x10\u00b0 recipient cells in the droplets for mitochondria transfer in 30 minutes.\n\n15. A method for quantitative control of mitochondrial transfer based on droplet microfluidics, comprising the steps of:\n\npreparing a first suspension, a second suspension, and an oil fluid;\n\nco-flowing of the first suspension, the second suspension, and the oil fluid to a system for quantitative control of mitochondrial transfer based on droplet microfluidics;\n\nDec. 21, 2023\n\nco-encapsulating the first and the second suspensions in droplets;\n\ncollecting the droplets; and\n\nco-culturing the first and the second suspensions in drop- lets.\n\n16. The method according to claim 15, wherein the first suspension is a mitochondrial recipient cell suspension and the isolated mitochondria suspension.\n\n17. The method according to claim 15, wherein the second suspension is an isolated mitochondria suspension.\n\n18. The method according to claim 15, wherein the droplets have a diameter of at less than 40 kum.\n\n19. The method according to claim 15, wherein the system. comprises a wave-like structure.\n\n20. The method according to claim 15, wherein the wherein the droplets comprise mitochondria, mitochondrial recipient cell, and mitochondrial recipient cell with mito- chondria inside.", "type": "Document"}}